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Abstract: Pre-pump arterial pressure (PreAP) is monitored to avoid generating 
excessive negative pressure. National Kidney Foundation K/DOQI clinical 
practice guidelines for vascular access recommend that PreAP should not fall 
below -250 mmHg because excessive negative PreAP can lead to a decrease in 
the delivery of blood flow, inadequate dialysis, and hemolysis. Nonetheless, 
these recommendations are consistently disregarded in clinical practice and 
pressure sensors are often removed from the dialysis circuit. Thus far, delivered 
blood flow has been reported to decrease at values more negative than -150 
mmHg of PreAP. These values have been analyzed by an ultrasonic flowmeter 
and not directly measured. Furthermore, no known group has evaluated whether 
PreAP-induced hemolysis occurs at a particular threshold. Therefore, the aim of 
this study was to clarify the importance of PreAP in the prediction of inadequate 
dialysis and hemolysis. By using different diameter needles, human blood 
samples from healthy volunteers were circulated in a closed dialysis circuit. The 
relationship between PreAP and delivered blood flow or PreAP and hemolysis 
was investigated. We also investigated the optimal value for PreAP using 
several empirical monitoring methods, such as a pressure pillow. Our 
investigation indicated that PreAP is a critical factor in the determination of 
delivered blood flow and hemolysis, both of which occured at pressure values 
more negative than -150 mmHg. With the exception of direct pressure 
monitoring, commonly used monitoring methods for PreAP were determined to 
be ineffective. We propose that the use of a vacuum monitor would permit 
regular measurement of PreAP. Key words: Pre-pump arterial pressure – 
Hemolysis – Blood flow – Pressure pillow – Vacuum monitor – Dialysis 
 
 Pre-pump arterial pressure (PreAP) is used to determine whether a prescribed 
dialyzer blood flow can be delivered without generating excessive negative 
pressure (1). National Kidney Foundation K/DOQI clinical practice guidelines for 
vascular access recommend that PreAP should not fall below -250 mmHg 
because excessive negative PreAP can lead to a decrease in delivered blood 
flow, inadequate dialysis, and hemolysis (2).  
 Nonetheless, even moderate negative pressure has been shown to result in a 
difference between the blood pump flow rate setting and delivered blood flow (3). 
Depner TA et al reported that neither hematocrit from 21% to 38% nor blood 
tubing affected delivered blood flow. Rather, PreAP was the primary determining 
factor for delivered blood flow and there was a demonstrated decrease in blood 
flow at values more negative than -150 mmHg (4). In this study, the delivered 
flow was investigated using the same type of ultrasonic flowmeter as reported in 
prior studies (5,6). However, the exact amount of delivered blood was not 
formally weighed. 
 PreAP monitoring has also been shown to be useful in the avoidance of harmful 
negative pressure which could give rise to blood damage. Blood damage is one 
of the primary complications in hemodialysis (HD). Any damage to red blood 
cells can decrease the cellular life span and contribute to anemia. Several 
factors contribute to hemolysis including shear stresses, blood/air interface and 
blood attachment to foreign surfaces. Among these, shear stress has been 
reported to be the primary source of hemolysis in HD. The highest shear stress 
is expected to occur in the dialysis needle, where the diameter of the tube is the 
smallest in the dialysis circuit (7). To our knowledge, the PreAP threshold at 
which hemolysis occurs has yet to be fully examined. 
 Despite K/DOQI recommendations, measurement of PreAP has not yet 
emerged as a clinical standard in worldwide practice (8). For example, in Japan, 
a collapsible pressure pillow has been used as a sensor for detecting PreAP. 
However, more cost effective systems including automatic priming and 
reinfusion systems using dialysate have become commonplace due to the 
efficiencies in time, labor and saline solution for priming. The dialysis circuit in 
the automatic reinfusion system eliminates a pillow because it can lead to the 
formation of clots of blood, that can be returned to patients using autotransfusion. 
Therefore, the oscillating movement of pulsating blood flow into the arterial 
chamber is currently the only way to estimate sufficient arterial blood supply. 
However, the reliability of this movement has yet to be studied as a measure to 
ensure adequate blood flow.  
 Therefore, the aim of this study was to re-evaluate the importance of PreAP 
monitoring in regards to the difference between the blood pump flow rate setting 
and delivered blood flow, and hemolysis. Furthermore, a secondary goal was to 
determine a useful method to monitor PreAP. We investigated the reliability of 
several candidates such as a pressure pillow.  
 
PATIENTS AND METHODS 
Ethics Statement 
 All clinical investigations were conducted according to the principles expressed 
in the Declaration of Helsinki and individuals’ data were analyzed anonymously. 
All patients and volunteers gave their informed, written consent. This study was 
approved by the Research Ethics Committee of Tokushima University.  
Design and subjects 
 This study included eight healthy volunteers and five patients with 
maintenance dialysis at Tokushima University Hospital. All of the volunteers 
were men aged 26 to 43 years (mean ± SD, 31.8 ± 5.8 years). Patients were 
aged 50 to 77 years (61.4 ± 11.6 years), and there were two men and three 
women. The duration of renal replacement therapy ranged from 1 to 120 months 
(52.0 ± 55.2 months). Two patients (40%) had diabetes mellitus. Dialysis 
modality for patients at Tokushima University Hospital was HD. Polyethersulfone 
membrane dialyzers were used. Every patient received 4-hour dialysis three 
times per week. Blood samples for biochemical data were obtained from 
arteriovenous shunt just at the start of the first HD session in this study (9). 
Hemoglobin and hematocrit values ranged from 8.1 to 10.6 mg/dL (9.6 ± 1.3 
mg/dL), and 25.8 to 34.2% (30.2 ± 3.9%), respectively. 
Measurement of PreAP, a decrease in blood flow with an ultrasonic 
flowmeter, hemolysis, and the length of pulsating movement (LPM) in vitro. 
 PreAP, detection of a decrease in blood flow with an ultrasonic flowmeter, 
hemolysis, and pulsating movement were assessed using the dialysis circuit 
shown in Supplementary figure 1A. The circuit used a PES-13S dialyzer 
(NIPRO, Osaka, Japan) and was primed with saline solution. Approximately 200 
mL of saline was filled in the circuit. Then, human blood from a healthy volunteer 
was drained at a speed of 25 mL/min for 12 minutes with a 16-gauge (16G) 
(outer diameter: 16G, 1.6 mm, inner diameter: 18G, 1.2 mm, length : 38 mm , 
NIPRO) needle from the arterial line and collected through the dialyzer and 
venous line with a 15G/16G (outer diameter : 15G/16G, 1.8/1.6 mm, inner 
diameter : 17G/18G, 1.4/1.2 mm, length : 38 mm, NIPRO) needle into a saline 
bag. Ten thousand units of heparin were administered initially, and 500 
units/hour was continued during the experiment. After blood collection was 
finished, the same size 15G/16G needle was attached to the arterial line and 
inserted into the blood collection bag. The blood/saline solution was inverted 
gently several times and circulated for 10 minutes at a speed of 50 mL/min to 
mix completely. The final hemoglobin and hematocrit ranges were 8.0 to 9.3 
mg/dL (8.8 ± 0.5 mg/dL), and 23.6 to 27.7% (26.2 ± 1.4%), respectively. Next, 
the blood pump flow rate was set to 100 mL/min and then increased by 50 
mL/min every 20 minutes. PreAP was analyzed with a vacuum monitor (Nagano 
Keiki, Nagano, Japan), delivered blood flow was detected with a Transonic 
HD02 monitor (Transonic systems Inc., Ithaca, NY, USA) (5,6) and LPM 
(Supplementary figure 2) was measured three minutes after the blood pump flow 
rate setting increase. Just before the subsequent flow increase, a 3 mL sample 
was passively collected in a 5 ml syringe. It was immediately transferred to a 2.7 
mL centrifuge tube with anticoagulant, spun down in the centrifuge and the 
resulting plasma was pipetted off into a 1.5 mL tube. Tubes with plasma were 
stored at -80℃ for further analysis. The cyanide-free method was used to 
measure plasma free hemoglobin (10). A standard curve of human hemoglobin 
was prepared using hemolysed human blood of known concentration. The 
plasma samples were then analyzed. Δplasma free hemoglobin was defined as 
the measured value minus initial plasma free hemoglobin. The maximum blood 
pump flow rate setting was 400 mL/min. After this first experiment, the needles 
used in the saline bag were exchanged with the alternate diameter needles (15G
→16G or 16G→15G). Again, PreAP, delivered blood flow detected with a 
Transonic HD02 monitor, and LPM were measured. 
Quantification of a decrease in blood flow by weighing the blood in vitro. 
 Following the analysis described above, the venous line 15G/16G needle was 
stuck into the other saline bag (Supplementary figure 1B). The blood delivered 
per minute was weighed and corrected to volume by the density. Blood density 
was determined by a pycnometer method (11). 
Investigation of PreAP and LPM in HD patients. 
 One hour after the HD session started, PreAP, delivered blood flow and LPM 
were measured as described above at a blood pump flow rate setting of 250 or 
200 mL/min. This procedure was performed during three serial HD sessions 
performed with 16G needles. Except patient number 1, the puncture site and the 
direction of the arterial needle (toward or against anastomosis) were nearly 
identical between each session. All of the three data sets were recorded. For 
patient number 1, we performed the experiment with the needle punctured both 
toward and against anastomosis. At the same time, we confirmed that the 
percentage decrease in delivered blood flow was less than 5% compared to the 
blood pump flow rate setting by using a Transonic HD02 monitor. 
Statistical analysis 
 All values are expressed as mean ± SD. Results were analyzed using paired 
t-tests. Statistical significance was defined by P less than 0.05. 
 
RESULTS 
 Initially, we investigated the significance of PreAP on the difference between 
the blood pump flow rate setting and delivered blood flow. The recorded 
difference occurred at values more negative than -150 mmHg regardless of 
needle diameter (Figure 1E). In this experiment, measured delivered blood flow 
(Figure 1A,B) was examined using the widely accepted ultrasonic flowmeter 
technique (5,6). Nonetheless, the accuracy of the machine is ± (blood pump 
flow rate setting × 0.06 + 8) mL/min according to the manufacturer’s 
instructions. For example, at a flow rate setting of 300 mL/min, the machine 
accuracy would be ± 26 mL/min or ± 8.7 %. In order to mitigate this potential 
error, delivered blood flow per minute was weighed and, regardless of needle 
diameter, the actual blood volume started to decrease at approximately -150 
mmHg (Figure 2E).  
 Next, we measured hemolysis with different needles and flow rates. Hemolysis 
occurred if PreAP fell below -150 mmHg with both needle diameters (Figure 3E). 
These results confirm that hemolysis started at comparable PreAP as that in the 
previous experiment, which was the primary determinant of the difference 
between the blood pump flow rate setting and delivered blood flow (Figure 2E). 
In summary, in this in vitro setting, both a decrease in delivered blood flow and 
hemolysis were not time or needle-dependent, but PreAP dependent. 
 Furthermore, we investigated the reliability of two alternate methods to detect a 
PreAP of -150 mmHg; degree of pulsating movement and collapse of a pressure 
pillow. LPM is an easy indicator of sufficient blood supply. In the same in vitro 
system, we measured LPM and determined that it increased in relation to PreAP. 
However, with the same PreAP, LPM was statistically different between both 
needle types (4.7 ± 0.5 cm at -201 mmHg with 16G vs. 5.4 ± 0.6 cm at -197 
mmHg of PreAP with 15G, Figure 4). Moreover, if PreAP was constant but the 
circuit tube was exchanged for one with a narrower lumen, LPM increased (data 
not shown). Therefore, LPM was correlated with PreAP, but also affected by 
needle diameter and other circuit equipment even in this simple in vitro setting.  
 The detection of PreAP was also attempted by touching a pressure pillow. 
However, all of six experienced clinical engineers and two doctors failed to 
detect the objective PreAP (-150 mmHg) blindly, despite advanced training in 
the collapse of the pillow with the PreAP. In fact, the pillow was far from 
collapsed at -150 mmHg of PreAP. The values detected varied among 
individuals and within trials of the same individual, ranging from -150 to -300 
mmHg. Thus, the pillow was only useful to detect an extreme decrease in blood 
flow and not reliable to determine the optimal PreAP. 
 In vivo, the relationship among blood flow, PreAP and LPM was evaluated in 
five HD patients. Initially, all PreAP data from every patient were less negative 
than -200 mmHg. Regardless of condition of puncture point, needle direction, 
and blood flow, PreAP was variable and LPM was not correlated with PreAP 
(Figure 5). These results imply that LPM was dependent not only on PreAP but 
also on other factors such as the direction of the needle or the interface of the 
needle opening and vessel wall.  
  
Discussion 
 In this study, we have demonstrated that PreAP is an important factor that 
affects both delivered blood flow and hemolysis. The threshold of PreAP that 
contributes to these problems was -150 mmHg. PreAP monitoring methods such 
as pulsating movement and a pressure pillow were not effective in the detection 
of optimal PreAP.  
 Excessive negative pressure has been demonstrated to be the primary cause 
of the difference between the blood pump flow rate setting and delivered blood 
flow (3). PreAP pressures more negative than -150 mmHg have been shown to 
cause a reduction in delivered blood flow in previous studies, which was 
supported by our data (4). We confirmed the effect of PreAP more negative than 
-150 mmHg on blood flow by using different gauge needles and quantifying the 
delivered blood by weighing directly. This suggests, at least in part, that PreAP is 
a critical factor in the delivery of actual blood flow in our experiment condition. 
The ultimate concern with actual blood flow rate not matching the blood pump 
flow rate setting is the concomitant decrease in blood clearance and delivered 
dialysis. Teruel JL et al. showed that the difference between the blood pump flow 
rate setting and delivered blood flow was related to PreAP, regardless of the 
needle gauge or blood pump flow rate setting from 300 to 400 mL/min. In this 
study, an ultrasonic sensor measured the decrease in blood flow to be 
approximately 10%,15%, and 20% at approximately -150,-200, and -250 mmHg 
of PreAP, respectively (3). Of note, this study did not measure small solute 
clearance. However, a 15% decrease in blood flow from 400 to 340 mL/min 
using a dialyzer with a mass transfer area coefficient of urea of 700 mL/min and 
a dialysate flow rate of 800 mL/min would be expected to result in an 8% 
decrease in urea clearance (12). Mehta HK et al. observed the impact of an 
increase in needle gauge in 22 HD patients. In this study, mean delivered blood 
flow measured by an ultrasonic sensor increased from 379 mL/min to 402 
mL/min. Mean PreAP became less negative from -230 mmHg to -172 mmHg. 
The percentage of reduction in urea (PRU) level increased from a mean of 
63.7% to 68.7% (13). According to the US Renal Data System database (14), a 
5% increase in PRU is associated with an 11% decrease in overall mortality up 
to a PRU of 70%. Therefore, the relationship between PreAP and actual 
delivered blood flow is quite important to the maintenance of adequate dialysis 
(15).  
 Blood flow also causes shear stress, which is one of the primary causes of 
hemolysis. Peripheral dialysis needles are expected to have the highest shear 
stresses within a dialysis circuit. Shear stress in the needle depends on the rate 
of blood flow (7). Blood flow rates are correlated with PreAP (3,4). Even in more 
complicated systems such as cardiopulmonary bypass, a combination of 
negative pressure and air interface had the largest rate of damage. Hemolysis 
was caused at pressures more negative than -120 mmHg (16). In our mock 
dialysis experiment, hemolysis was dependent on PreAP regardless of needle 
diameter. The optimal PreAP to prevent hemolysis was less negative than -150 
mmHg, which can also prevent a decrease in blood flow. Hemolysis can be 
subclinical in a short period at moderate PreAP. However, considering the long 
life span of HD patients and low incidence of kidney transplantation in Japan, 
any injury to red blood cells should be averted (17). Thus, PreAP detection is 
critically important.  
 Even in our simplified setting, in which blood was abundant and static, 
pulsating movement was not decisive in the prediction of PreAP. A pressure 
pillow was only useful to detect extremely low PreAP, as well as roller pump 
tubing collapse (4). These results imply that direct PreAP monitoring by a 
vacuum monitor is the only way to avoid harmful, but not extreme, negative 
pressure.  
 Limitations of this study should be noted. Hemolysis in HD patients was not 
monitored. In Japan, blood flow rates are prescribed at or less than 250 mL/min 
using 16G needles in most HD patients. In this context, PreAP does not 
generally fall below -200 mmHg, as was evidenced in this study (Figure 5). 
PreAP of -200 mmHg caused minimal hemolysis in the approximately 500 mL 
pool of blood/saline in our in vitro experiment (Figure 3). Therefore, we did not 
endeavor to detect hemolysis at PreAP less negative than -200 mmHg in vivo 
according to the previous report (18). For ethical reasons, we could not prescribe 
a higher flow rate to induce more negative pressure in HD patients due to the 
potential complication of inadequate dialysis and hemolysis, given our results. 
 
CONCLUSION 
 To avoid inadequate dialysis in vivo, arteriovenous shunt flow or delivered 
blood flow serial monitoring have become relatively easy using either an 
ultrasound technique (19-21) or an ultrasonic flowmeter such as HD02. However, 
detection of subclinical hemolysis remains difficult. Lactate dehydrogenase is 
nonspecific and affected by other factors such as liver dysfunction, and plasma 
free hemoglobin is not regularly analyzed. PreAP is definitely an important factor 
in the prediction of hemolysis. It is difficult to determine the optimal PreAP 
threshold by monitoring methods currently available. Therefore, we strongly 
emphasize the importance of PreAP monitoring to prevent hemolysis.  
 
Acknowledgement: We thank Masashi Miyoshi, Ryo Yamamoto, Atsushi 
Fujinaka, Naoki Tokunaga, Motoki Sugasaki, Kumiko Inoi, Takayuki Nakao, 
Chihiro Inoue, Kento Oota (The University of Tokushima) for excellent technical 
assistance and Ryosuke Ogata, Keisuke Morinishi, Seiji Kobayashi, Miki Oonishi, 
Aiko Takamatsu, Kanae Yamada, Yoko Okazawa, Akiyo Muramoto (The 
University of Tokushima) for clinical assistance. 
 
Concept/design : Kojiro Nagai 
Data analysis/interpretation : Eriko Shibata, Kojiro Nagai 
Drafting article : Eriko Shibata, Yusuke Chikata, Michael Hann, Kojiro Nagai 
Critical revision of article : Taichi Murakami, Motokazu Matsuura, Hideharu 
Abe, Toshio Doi 
Statistics : Eriko Shibata, Kojiro Nagai 
Data collection : Eriko Shibata, Kojiro Nagai, Risa Takeuchi, Yasuhiro Noda, 
Tomomi Makino, Sakiya Yoshimoto, Hiroyuki Ono, Sayo Ueda, Masanori 
Tamaki, Taichi Murakami, Motokazu Matsuura  
 
REFERENCES 
1. Vascular Access Work Group. Clinical practice guidelines for vascular access. 
Am J Kidney Dis 2006;48 Suppl 1:S176-247. 
2. Vascular Access Work Group. Clinical practice guidelines for vascular access. 
Am J Kidney Dis 2006;48 Suppl 1:S248-73. 
3. Teruel JL, Fernández Lucas M, Marcén R, et al. Differences between blood 
flow as indicated by the hemodialysis blood roller pump and blood flow measured 
by an ultrasonic sensor. Nephron 2000;85:142-7. 
4. Depner TA, Rizwan S, Stasi TA. Pressure effects on roller pump blood flow 
during hemodialysis. ASAIO Trans 1990;36:M456-9. 
5. Tan J, Mohan S, Herbert L, et al. Identifying hemodialysis catheter 
recirculation using effective ionic dialysance. ASAIO J 2012;58:522-5. 
6. Basile C, Lomonte C, Vernaglione L, et al. The relationship between the flow 
of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol 
Dial Transplant 2008;23:282-7. 
7. De Wachter DS, Verdonck PR Verhoeven RF, Hombrouckx RO. Red cell 
injury assessed in a numeric model of a peripheral dialysis needle. ASAIO J 
1996;42:M524-9.  
8. Polaschegg HD. Practical matters: Neglected safety aspects in hemodialysis 
machines and their related problems. Hemodialysis Horizons 65–8. Available at: 
http://www.aami.org/publications/hh/Neglected.Polaschegg.pdf  
9. Shibata M, Nagai K, Doi T, et al. Blood color is influenced by inflammation and 
independently predicts survival in hemodialysis patients : quantitative evaluation 
of blood color. Artif Organs 2012;36:992-8. 
10. Bauer N, Moritz A. Evaluation of three methods for measurement of 
hemoglobin and calculated hemoglobin variables with the ADVIA 120 and  
ADVIA 2120 systems in goats. J Vet Diagn Invest 2008;20:593–7. 
11. Phillips RA, Van Slyke DD, Hamilton PB, et al. Measurement of specific 
gravities of whole blood and plasma by standard copper sulfate solutions. J Biol 
Chem 1950;183:305-30. 
12. Ward RA. Blood flow rate: An important determinant of urea clearance and 
delivered Kt/V. Adv Ren Replace Ther 1999;6:75-9. 
13. Mehta HK, Deabreu D, McDougall JG, Goldstein MB. Correction of 
discrepancy between prescribed flow rates in chronic hemodialysis patients  
with use of larger gauge needles. Am J Kid Dis 2002;39:1231-5. 
14. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient 
mortality. Kidney Int 1996;50:550-6. 
15. Mandolfo S, Borlandelli S, Ravani P, Imbasciati E. How to improve dialysis 
adequacy with vascular access problems. J Vasc Access 2006;7:53-9. 
16. Mulholland JW, Massey W, Shelton JC. Investigation and quantification of 
the blood trauma caused by the combined dynamic forces experienced during 
cardiopulmonary bypass. Perfusion 2000;15:485-94. 
17. Yamagata K, Yagisawa T, Nakai S, et al. Prevalence and incidence of chronic 
kidney disease stage G5 in Japan. Clin Exp Nephrol 2014 May 13. [Epub ahead 
of print]. 
18. Techert F, Techert S, Woo L, et al. High blood flow rates with adjustment of 
needle diameter do not increase hemolysis during hemodialysis treatment. J 
Vasc Access 2007;8:252-7.  
19. Wiese P, Nonnast-Daniel B. Colour Doppler ultrasound in dialysis 
access. Nephrol Dial Transplant 2004;19:1956-63. 
20. Teodorescu V, Gustavson S, Schanzer H. Duplex ultrasound evaluation of 
hemodialysis access: a detailed protocol. Int J Nephrol 2012 Epub 2012 Jul 10. 
21. Paulson WD, Moist L, Lok CE. Vascular access surveillance: an ongoing 
controversy. Kidney Int 2012;81:132-42. 
 
FIGURE LEGENDS 
FIG. 1. The relationship among pre-pump arterial pressure, blood pump flow rate 
setting and blood flow measured by an ultrasonic flowmeter.  
 PreAP, detection of a decrease in blood flow with an ultrasonic flowmeter were 
assessed using the dialysis circuit shown in Supplementary figure 1A. The 
dotted line in figure 1A,B represents the line of identity. All values are expressed 
as means ± SD (N=8).  
FIG. 2. The relationship among pre-pump arterial pressure, blood pump flow rate 
setting and directly measured blood flow.  
 PreAP, detection of a decrease in blood flow were assessed using the dialysis 
circuit shown in Supplementary figure 1B. The blood delivered per minute was 
weighed and corrected to volume by blood density. The dotted line in figure 2A,B 
represents the line of identity. All values are expressed as mean ± SD (N=4). 
FIG. 3. The relationship among pre-pump arterial pressure, blood pump flow rate 
setting and hemolysis. 
 PreAP, hemolysis were assessed using the dialysis circuit shown in 
Supplementary figure 1A. A 3 mL sample was passively collected in a 5 ml 
syringe. It was immediately transferred to a 2.7 mL centrifuge tube with 
anticoagulant, spun down in the centrifuge and the resulting plasma was 
pipetted off into a 1.5 mL tube. The cyanide-free method was used to measure 
plasma free hemoglobin. All values are expressed as mean ± SD (N=3 for 15G 
and N=5 for 16G). 
FIG. 4. The relationship between pre-pump arterial pressure and the length of 
pulsating movement. 
 PreAP, the length of pulsating movement were assessed using the dialysis 
circuit shown in Supplementary figure 1A. All values are expressed as mean ± 
SD (N=8). *P < 0.01. 
FIG. 5. The relationship between pre-pump arterial pressure and the length of 
pulsating movement in HD patients. 
 At a blood pump flow rate setting of 250 (A,B) or 200 (C,D) mL/min, PreAP, the 
length of pulsating movement were assessed in HD patients. The arterial 16G 
needle was inserted toward anastomosis (A,C) or against anastomosis (B,D). 
The percentage of decrease in delivered blood flow was less than 5% compared 
to the blood pump flow rate setting. All of the three data sets from serial HD 
session were recorded. The number attached to each value shows the patient 
number. 
 
SUPPLEMENTARY FIGURE LEGENDS 
Supplementary FIG.1. Schematic of the mock dialysis circuit used in hemolysis 
detection (A) and used to quantify actual blood flow (B). 
Supplemantary FIG.2. The length of pulasating movement. The amplitude of 
blood flow surface movement shown in this figure was measured. 
 
